Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris

International Journal of Cardiology

Volumn 123, Issue 2, 2008, Pages 195-196

  Saha, Samir ^a   Berglund, Margareta ^a   Sylvén, Christer ^a   Gordon, Allan ^a   Agewall, Stefan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angina pectoris; Aspirin; Clopidogrel; Platelet activity

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; COLLAGEN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; LOADING DRUG DOSE; MONOTHERAPY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME;

ANGINA PECTORIS; ASPIRIN; CHRONIC DISEASE; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 37049039058     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.136     Document Type: Article

References (7)

1. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
2. Juul-Moller S., Edvardsson N., Jahnmatz B., et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 340 (1992) 1421-1425
3. Mackie Ij., Jones R., and Machin S.J. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol 37 (1984) 874-878
4. Ingerman-Wojenski C.M., and Silver M.J. A quick method for screening platelet dysfunctions using the whole blood lumiaggregometer. Thromb Haemost 51 (1984) 154-156
5. Bhatt D.L., Fox K.A., Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
6. Herbert J.M., Savi P., and Maffrand J.P. Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist. Eur Heart J 21 (1999) A31-A40
7. Kabbani S.S., Watkins M.W., Ashikaga T., et al. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186